Advance your academic career, collaborate globally, and expand your network— join now !

Silvia Schenone

Prof. Silvia Schenone

Dipartimento di Farmacia, Università degli Studi di Genova, Viale Benedetto XV, ...

Share Link

Share

Information

Silvia Schenone, Full Professor. Silvia Schenone obtained a degree in Chemistry and Pharmaceutical Technologies in 1987 and a degree in Pharmacy in 1988 from the University of Genoa. In 1991, she received her PhD in Medicinal Chemistry. Since 2016, she has been a Full Professor. Furthermore, she is currently the Head of the Department of Pharmacy, at the University of Genoa. Silvia Schenone is a medicinal chemist involved in the design, synthesis, and identification of organic molecules endowed with pharmacological activity. She is also interested in structural studies of biological macromolecules and molecular modeling applications in medicinal subjects. She started her work in the field of anti-inflammatory agents, then moved to adenosine receptor antagonists, and in the last few years, she has been working on the design and synthesis of protein kinase inhibitors as anticancer agents. Her research on the latter topic has led to the publication of 90 articles and four patents. Her other expertise is related to ADME (adsorption, distribution, metabolism, and excretion) studies in silico, in vitro, and in vivo.

Research Keywords & Expertise

Heterocyclic Chemistry
anticancer agents
drug delivery systems
protein kinase inhibit...
Prodrug formulations

Fingerprints

5%
anticancer agents
5%
drug delivery systems
5%
protein kinase inhibitors

Short Biography

Silvia Schenone, Full Professor. Silvia Schenone obtained a degree in Chemistry and Pharmaceutical Technologies in 1987 and a degree in Pharmacy in 1988 from the University of Genoa. In 1991, she received her PhD in Medicinal Chemistry. Since 2016, she has been a Full Professor. Furthermore, she is currently the Head of the Department of Pharmacy, at the University of Genoa. Silvia Schenone is a medicinal chemist involved in the design, synthesis, and identification of organic molecules endowed with pharmacological activity. She is also interested in structural studies of biological macromolecules and molecular modeling applications in medicinal subjects. She started her work in the field of anti-inflammatory agents, then moved to adenosine receptor antagonists, and in the last few years, she has been working on the design and synthesis of protein kinase inhibitors as anticancer agents. Her research on the latter topic has led to the publication of 90 articles and four patents. Her other expertise is related to ADME (adsorption, distribution, metabolism, and excretion) studies in silico, in vitro, and in vivo.